Magnus Persson - 30 Jun 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
30 Jun 2023
Transactions value $
$0
Form type
4
Filing time
05 Jul 2023, 16:07:12 UTC
Previous filing
04 Apr 2023
Next filing
21 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +28,308 $0 28,308 30 Jun 2023 Common Stock 28,308 $0.3552 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the stock option will immediately vest on the date that it is granted.